Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avivagen Inc VIVXF

Avivagen Inc. is a Canada-based life sciences company. The Company is focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health and performance. The Company’s operations as one segment, products based on OxC-beta Technology. It OxC-beta technology is derived from its discoveries about B-carotene and other carotenoids, compounds that give certain fruits and vegetables their bright colors. OxC- beta Livestock is a proprietary product, an alternative to the antibiotics commonly added to livestock feeds. The product is available for sale in the United States, Mexico, Philippines, Taiwan, New Zealand, Thailand, Australia and Malaysia. It offers OxC-beta to approximately 46.6 million food animals (poultry, swine, and dairy cattle), 133,820 dogs and 4,000 people.


GREY:VIVXF - Post by User

Bullboard Posts
Comment by gijo333on Feb 04, 2017 10:53am
145 Views
Post# 25799403

RE:RE:RE:RE:Avivagen Undertakes Human Health Proof-of-Concept

RE:RE:RE:RE:Avivagen Undertakes Human Health Proof-of-Concept No question that he is entitled to do as he wishes. My comment is based on the fact that he is a high level insider and knows much more than you and I. He could have raised the $51k a few weeks sooner with 300000 shares. Also, a positive activity report from an up and coming Asian update could have had a similar impact. Based on these developments I now suspect SP will continue to decline for some time. I was encouraged by the actual sale on some product. After years of owning the stock, reading amazing reports of trial after trial resulting in no one wanting to buy. When you are in sales the easiest thing to accomplish is getting a potential customer to use what you are selling for free. Most lousy sales people do gravitate to this strategy. It's called "the hope strategy"  or "puppy dog strategy".  You can imagine how surprised and excited when a sale actually and finally occurred. I had no doubt of anything but a successful outcome. Now a high level insider decides that Jan 27  is a good time to liquidate some shares. But then again if his understanding of SP value is on the same level with understanding the sales concept I do agree  there is surely no reason for the concern. 
Bullboard Posts